Evidence map›Paper›PMID 41338928›Full record

ReviewLife science alliance2026

Conserved 3D genome reorganization during DNA repair.

Veysel Oğulcan Kaya, Ogün Adebali, Hanspeter Naegeli, Michelle N Yancoskie

Abstract readReview
In one paragraph

Review in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Veysel Oğulcan KayaThe Molecular Biology, Genetics, and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabancı University, Istanbul, Türkiye.ORCID 0000-0002-3447-0735
Ogün AdebaliThe Molecular Biology, Genetics, and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabancı University, Istanbul, Türkiye.ORCID 0000-0001-9213-4070
Hanspeter NaegeliInstitute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-5762-1359
Michelle N YancoskieInstitute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland myancoskie@vetpharm.uzh.ch.ORCID 0000-0002-9895-5301

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mammalian genome is hierarchically structured to maintain accessibility and flexibility for essential nuclear processes such as transcription and DNA repair. A recent study using high-throughput 3D genome mapping reveals that nucleotide excision repair triggers large-scale chromatin rearrangements, reinforcing topologically associating domains and chromatin compartments. Notably, similar principles of chromatin stabilization are observed during double-strand break repair, consistent with the notion that chromatin restructuring may be an active and conserved DNA repair strategy rather than a passive consequence of damage. The observed stabilization is postulated to optimize repair efficiency by reducing the search space for damage, enhancing DNA accessibility at damage sites, increasing local concentrations of repair factors, and preventing aberrant chromosomal rearrangements. By synthesizing emerging evidence on nucleotide excision repair-driven chromatin dynamics and its parallels with double-strand break repair, this review examines how genome architecture actively shapes the DNA damage response and highlights broader implications for genetic diseases and therapeutic strategies.

Indexed as

DNA RepairGenomeAnimalsChromatinChromatin Assembly and DisassemblyDNA Breaks, Double-StrandedDNA DamageHumansChromatin

Identifiers

PMID41338928
PMCPMC12676481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.